furue masutaka
furue masutaka
Professor of Kyushu University
Verified email at
Cited by
Cited by
Anti–interleukin-31 receptor A antibody for atopic dermatitis
T Ruzicka, JM Hanifin, M Furue, G Pulka, I Mlynarczyk, A Wollenberg, ...
New England Journal of Medicine 376 (9), 826-835, 2017
Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFα and IL‐1α
H Torisu, M Ono, H Kiryu, M Furue, Y Ohmoto, J Nakayama, Y Nishioka, ...
International journal of cancer 85 (2), 182-188, 2000
Visual analogue scale: evaluation of the instrument for the assessment of pruritus
A Reich, M Heisig, NQ Phan, K Taneda, K Takamori, S Takeuchi, M Furue, ...
Acta Dermato Venereologica 92 (5), 497, 2012
Periostin promotes chronic allergic inflammation in response to Th2 cytokines
M Masuoka, H Shiraishi, S Ohta, S Suzuki, K Arima, S Aoki, S Toda, ...
The Journal of clinical investigation 122 (7), 2590-2600, 2012
Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population
T Hirota, A Takahashi, M Kubo, T Tsunoda, K Tomita, M Sakashita, ...
Nature genetics 44 (11), 1222-1226, 2012
Guidelines for management of atopic dermatitis
H Saeki, M Furue, F Furukawa, M Hide, M Ohtsuki, I Katayama, R Sasaki, ...
The Journal of dermatology 36 (10), 563-577, 2009
Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies
M Furue, T Chiba, G Tsuji, D Ulzii, M Kido-Nakahara, T Nakahara, ...
Allergology international 66 (3), 398-403, 2017
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
J Schmitt, PI Spuls, KS Thomas, E Simpson, M Furue, S Deckert, M Dohil, ...
Journal of allergy and clinical immunology 134 (4), 800-807, 2014
A randomized double-blind trial of intravenous immunoglobulin for pemphigus
M Amagai, S Ikeda, H Shimizu, H Iizuka, K Hanada, S Aiba, F Kaneko, ...
Journal of the American Academy of Dermatology 60 (4), 595-603, 2009
Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement
T Nakahara, Y Moroi, H Uchi, M Furue
Journal of dermatological science 42 (1), 1-11, 2006
Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study
K Kabashima, M Furue, JM Hanifin, G Pulka, A Wollenberg, R Galus, ...
Journal of Allergy and Clinical Immunology 142 (4), 1121-1130. e7, 2018
The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology
J Schmitt, C Apfelbacher, PI Spuls, KS Thomas, EL Simpson, M Furue, ...
Journal of Investigative Dermatology 135 (1), 24-30, 2015
An environmental contaminant, benzo (a) pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling …
G Tsuji, M Takahara, H Uchi, S Takeuchi, C Mitoma, Y Moroi, M Furue
Journal of dermatological science 62 (1), 42-49, 2011
Emerging role of interleukin‐31 and interleukin‐31 receptor in pruritus in atopic dermatitis
M Furue, K Yamamura, M Kido‐Nakahara, T Nakahara, Y Fukui
Allergy 73 (1), 29-36, 2018
Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis
M Furue, H Terao, W Rikihisa, K Urabe, N Kinukawa, Y Nose, T Koga
British Journal of Dermatology 148 (1), 128-133, 2003
Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis
M Furue
International journal of molecular sciences 21 (15), 5382, 2020
Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting
J Schmitt, P Spuls, M Boers, K Thomas, J Chalmers, E Roekevisch, ...
Allergy 67 (9), 1111-1117, 2012
Cytokines and chemokines in the epidermis
H Uchi, H Terao, T Koga, M Furue
Journal of dermatological science 24, S29-S38, 2000
Prevalence of dermatological disorders in Japan: a nationwide, cross‐sectional, seasonal, multicenter, hospital‐based study
M Furue, S Yamazaki, K Jimbow, T Tsuchida, M Amagai, T Tanaka, ...
The Journal of dermatology 38 (4), 310-320, 2011
B7‐1 expression of Langerhans cells is up‐regulated by proinflammatory cytokines, and is down‐regulated by interferon‐γ or by interleukin‐10
CH Chang, M Furue, K Tamaki
European journal of immunology 25 (2), 394-398, 1995
The system can't perform the operation now. Try again later.
Articles 1–20